1. Home
  2. GHG vs CUE Comparison

GHG vs CUE Comparison

Compare GHG & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.13

Market Cap

116.0M

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$29.00

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
CUE
Founded
2004
2014
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
124.5M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
GHG
CUE
Price
$1.13
$29.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$120.00
AVG Volume (30 Days)
4.5K
138.8K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
N/A
$27,466,000.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
195.75
52 Week Low
$1.10
$0.17
52 Week High
$2.57
$45.50

Technical Indicators

Market Signals
Indicator
GHG
CUE
Relative Strength Index (RSI) 51.08 N/A
Support Level N/A N/A
Resistance Level $1.16 N/A
Average True Range (ATR) 0.03 0.00
MACD 0.00 0.00
Stochastic Oscillator 55.56 0.00

Price Performance

Historical Comparison
GHG
CUE

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: